|
rs1048943
|
|
Prostate carcinoma
|
|
0.050 |
GeneticVariation
|
BEFREE |
<b>Conclusion.</b> This meta-analysis revealed a clear association between rs104</span>8943 and rs4646903 polymorphisms of the <i>CYP1A1</i> gene but not between CYP1B1 rs10012, rs162549, rs1800440, and rs2551188 polymorphisms and the risk of PCa.
|
30765615 |
2019 |
|
rs2551188
|
|
Prostate carcinoma
|
|
0.030 |
GeneticVariation
|
BEFREE |
<b>Conclusion.</b> This meta-analysis revealed a clear association between rs1048943 and rs4646903 polymorphisms of the <i>CYP1A1</i> gene but not between CYP1B1 rs10012, rs162549, rs1800440, and rs2551188 polymorphisms and the risk of PCa.
|
30765615 |
2019 |
|
rs4646903
|
|
Prostate carcinoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
<b>Conclusion.</b> This meta-analysis revealed a clear association between rs1048943 and rs4646903 polymorphisms of the <i>CYP1A1</i> gene but not between CYP1B1 rs10012, rs162549, rs1800440, and rs2551188 polymorphisms and the risk of PCa.
|
30765615 |
2019 |
|
rs2394882
|
|
Prostate carcinoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
<b>Conclusion:</b> Our results suggest that rs2394882 is prognostically relevant in prostate cancer, possibly by modulating the expression of the CSC gene <i>POU5F1</i>.
|
29104488 |
2017 |
|
rs8752
|
|
Prostate carcinoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
<b>Conclusions:</b> rs8752 in the 3'untranslated region (UTR) of the 15-hydroxyprostaglandin dehydrogenase (<i>HPGD</i>) gene was found to be responsible for the susceptibility to prostate cancer in Chinese individuals.
|
29187884 |
2017 |
|
rs662
|
|
Prostate carcinoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
<b>Conclusions:</b> We reported by the first time a correlation between rs662 (PON1) and PCa aggressiveness.
|
31647334 |
2019 |
|
rs1056836
|
|
Prostate carcinoma
|
|
0.100 |
GeneticVariation
|
BEFREE |
<b>RESULTS:</b><i>CYP1B1</i> rs1056836 variant was associated with decreased risk of PCa [odds ratio (OR): 0.80; 95% confidence interval (CI): 0.68-0.99, <i>P</i> = 0.041].
|
29344273 |
2018 |
|
rs12611084
|
|
Prostate carcinoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
<i>DPF1</i> rs12611084 was inversely associated with ER-negative breast, endometrioid ovarian, and overall and aggressive prostate cancer risk (OR = 0.93; 95% CI = 0.91-0.96; q = 0.005).
|
28115406 |
2017 |
|
rs2297441
|
|
Prostate carcinoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
<i>RTEL1</i> rs2297441 [odds ratio (OR): 1.23; 95% confidence interval (CI): 1.03-1.46, <i>P</i> = 0.021] and rs3208008 (OR: 1.23; 95% CI: 1.03-1.46) were associated with PCa risk.
|
31762827 |
2019 |
|
rs3208008
|
|
Prostate carcinoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
<i>RTEL1</i> rs2297441 [odds ratio (OR): 1.23; 95% confidence interval (CI): 1.03-1.46, <i>P</i> = 0.021] and rs3208008 (OR: 1.23; 95% CI: 1.03-1.46) were associated with PCa risk.
|
31762827 |
2019 |
|
rs3783553
|
|
Prostate carcinoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
4-bp insertion/deletion (rs3783553) polymorphism within the 3'UTR of IL1A contributes to the risk of prostate cancer in a sample of Iranian population.
|
29023981 |
2018 |
|
rs9282858
|
|
Prostate carcinoma
|
|
0.100 |
GeneticVariation
|
BEFREE |
Prostate cancer and BPH were not associated with the alanine-49 to threonine single nucleotide polymorphism and the (TA)n repeat.
|
16018939 |
2005 |
|
rs780354238
|
|
Prostate carcinoma
|
|
0.030 |
GeneticVariation
|
BEFREE |
Prostate-cancer-associated I260M variant of DNA polymerase beta is a sequence-specific mutator.
|
16313169 |
2005 |
|
rs1056836
|
|
Prostate carcinoma
|
|
0.100 |
GeneticVariation
|
BEFREE |
Prostate cancer risk and aggressiveness associated with the CYP1B1 4326C/G (Leu432Val) polymorphism: a meta-analysis of 2788 cases and 2968 controls.
|
22504876 |
2012 |
|
rs137852593
|
|
Prostate carcinoma
|
|
0.040 |
GeneticVariation
|
BEFREE |
R726L androgen receptor mutation is uncommon in prostate cancer families in the united states.
|
12539229 |
2003 |
|
rs137852593
|
|
Prostate carcinoma
|
|
0.040 |
GeneticVariation
|
BEFREE |
R726L substitution in the hormone binding region of androgen receptor was found in 1 prostate cancer family but no previously uncharacterized germline mutations were detected.
|
14665948 |
2004 |
|
rs12329760
|
|
Prostate carcinoma
|
|
0.030 |
GeneticVariation
|
BEFREE |
Met160Val polymorphism in the TRMPSS2 gene and risk of prostate cancer in a population-based case-control study.
|
15065083 |
2004 |
|
rs486907
|
|
Prostate carcinoma
|
|
0.100 |
GeneticVariation
|
BEFREE |
Arg462Gln sequence variation in the prostate-cancer-susceptibility gene RNASEL and age of onset of hereditary non-polyposis colorectal cancer: a case-control study.
|
16054567 |
2005 |
|
rs2279343
|
|
Prostate carcinoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
Lys262Arg polymorphism of the CYP2B6 gene may be a genetic marker for evaluating the risk of sporadic prostate cancer in native Japanese men.
|
19425200 |
2009 |
|
rs1800562
|
|
Prostate carcinoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
C282Y/H63D compound heterozygotes were not at increased risk for colorectal cancer (HR = 1.27; 95% CI = 0.80, 2.01), breast cancer (HR = 1.16; 95% CI = 0.74, 1.84), or prostate cancer (HR = 1.08; 95% CI = 0.68, 1.70).
|
20099304 |
2010 |
|
rs10993994
|
|
Prostate carcinoma
|
|
0.800 |
GeneticVariation
|
BEFREE |
rs10993994 in MSMB promoter affects serum MSMB expression, contributes to the genetic predisposition to prostate cancer in southern Chinese Han population.
|
20333697 |
2010 |
|
rs4986791
|
|
Prostate carcinoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
Thr399Ile also may be connected with gallbladder cancer, and both of these polymorphisms apparently have no impact on risk of prostate cancer.
|
21081146 |
2011 |
|
rs351855
|
|
Prostate carcinoma
|
|
0.080 |
GeneticVariation
|
BEFREE |
Gly-388Arg polymorphism of FGFR-4 most likely contributes to susceptibility to prostate cancer, especially in men of European descent.
|
21625079 |
2011 |
|
rs1217691063
|
|
Prostate carcinoma
|
|
0.100 |
GeneticVariation
|
BEFREE |
C677T of the MTHFR gene may provide protective effects on susceptibility to prostate cancer risk.
|
22370724 |
2012 |
|
rs138213197
|
|
Prostate carcinoma
|
|
0.800 |
GeneticVariation
|
BEFREE |
G84E mutation in HOXB13 is firmly associated with prostate cancer risk: a meta-analysis.
|
24026887 |
2014 |